Martin Brenner - 31 Mar 2023 Form 4 Insider Report for iBio, Inc. (IBIO)

Role
Interim Chief Executive Officer and Chief Scientific Officer
Signature
/s/ Martin Brenner
Issuer symbol
IBIO
Transactions as of
31 Mar 2023
Net transactions value
$0
Form type
4
Filing time
03 Apr 2023, 16:02:57 UTC
Previous filing
28 Mar 2023
Next filing
24 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IBIO Common Stock Award $0 +50,000 +23% $0.000000 266,159 31 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 50,000 shares of iBio, Inc. (the "Company") common stock, $0.001 par value per share (the "Common Stock") represented by 50,000 restricted stock units ("RSUs") granted under the Company's 2020 Omnibus Equity Incentive Plan, (the "2020 Plan"). Each RSU represents a contingent right to receive one share of Common Stock. The 50,000 RSUs vest pro rata quarterly over 12 months beginning April 1, 2023.

Remarks:

Interim Chief Executive Officer and Chief Scientific Officer